viIMMUNE is an emerging biopharmaceutical company dedicated to the discovery and commercialization of innovative antiviral drugs. As a clinical stage company, viIMMUNE exploits small molecules as inhibitors of different enzymes in pathogenic viruses life cycle. Our mission at viIMMUNE is to help alleviate human suffering by discovering long-acting antiviral therapeutics through innovative approaches.
viIMMUNE technology is based on cutting-edge science driven by the goal of developing therapeutics that last longer and give the patient more protection against viral diseases. Our proprietary library of small molecule candidates is stringently analyzed by our R&D team to select and develop agents optimally suited for this therapeutic approach.
Our mission at viIMMUNE is to help alleviate human suffering by discovering long-acting antiviral therapeutics through innovative approaches.